EP1765148A1 - Detecteur d'analyte en metal composite - Google Patents

Detecteur d'analyte en metal composite

Info

Publication number
EP1765148A1
EP1765148A1 EP04776794A EP04776794A EP1765148A1 EP 1765148 A1 EP1765148 A1 EP 1765148A1 EP 04776794 A EP04776794 A EP 04776794A EP 04776794 A EP04776794 A EP 04776794A EP 1765148 A1 EP1765148 A1 EP 1765148A1
Authority
EP
European Patent Office
Prior art keywords
sensor
core
metal
electrochemically active
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP04776794A
Other languages
German (de)
English (en)
Other versions
EP1765148A4 (fr
Inventor
Kenneth W Ward
Richard S Sass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare LLC
Original Assignee
Isense Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isense Corp filed Critical Isense Corp
Priority to EP11153393A priority Critical patent/EP2335566A1/fr
Publication of EP1765148A1 publication Critical patent/EP1765148A1/fr
Publication of EP1765148A4 publication Critical patent/EP1765148A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/12—Manufacturing methods specially adapted for producing sensors for in-vivo measurements
    • A61B2562/125—Manufacturing methods specially adapted for producing sensors for in-vivo measurements characterised by the manufacture of electrodes

Definitions

  • the typical metal used for such a wire sensor is platinum, which is electrochemically active and generally very useful in sensing applications. Platinum, however, is a weak metal that is easily broken with only a little flexure. Moreover, the electrochemical nature of platinum surfaces is only imperfectly understood. Efforts to make sensors from very thin platinum wires that are stranded together, thereby providing greater flex resistance, have encountered negative effects on the biochemical reactivity of the more complex platinum surface. Also, platinum is very expensive costing on the order of $ 25 - $30 per gram. For a multiple use sensing assembly incorporating a multiplicity of single use sensing elements, this may be a considerable expense.
  • the present invention is a sensor adapted to, at least in part, be inserted into a mammalian body.
  • the sensor comprises a core of a structurally robust material and a plated portion, comprising an electrochemically active metal plated onto at least a portion of the core.
  • the present invention is a method for the continuous monitoring of an analyte within a mammalian body.
  • the method includes inserting at least a portion of a sensor into the mammalian body, continuously monitoring any electric current produced by at least a portion of the sensor.
  • the sensor includes a core of structurally robust material and a plated portion, comprising an electrochemically active metal plated onto at least a portion of the core.
  • the present invention is a method of producing a sensor that is adapted to, at least in part, be inserted into a mammalian body and dwell within the mammalian body for at least an hour.
  • FIG. 1 is a side cross-sectional view of a sensing element according to the present invention. PREFERRED METHODS OF PRACTICING THE INVENTION Referring to FIG. 1
  • sensing element 12 includes a bimetallic wire 20 that, when a voltage is placed on wire 20 relative to a reference electrode, in conjunction with a membrane system 22 reacts to the presence of glucose and oxygen (in some preferred embodiments, glucose only) by creating a current.
  • Wire 20 is coated with a protective layer 23, made of durable, non-toxic material such as polyimide, except for where coated by membrane system 22.
  • protective layer 23 is dip-coated onto wire 20 and then removed, preferably with an excimer or ND:YAG laser in the area in which membrane system 22 is to be applied. In other preferred embodiments there is no protective layer 23 and the entire wire 20 is coated with membrane assembly 22.
  • Wire 20 may have a diameter on the order of 227 microns and has a wire core 24 of structurally robust metal such as stainless steel or tantalum that is 226 microns thick and an electrochemically active layer 26, such as platinum, that is less than a micron thick.
  • wire 20 is 177 microns in diameter
  • core 24 is 157 microns in diameter and is made of tantalum
  • layer 26 is 10 microns thick and is a platinum foil that has been joined to core 24.
  • wire core 24 may be of any structurally robust metal, such as tantalum, stainless steel or nitinol, which is an alloy of nickel and titanium.
  • Tantalum and nitinol are desirable because they are both naturally flexible. This is of particular importance if sensing element 12 is to be inserted in a patient and worn for a period of days.
  • core 24 could be made of polymeric material or a glass fiber.
  • Electrochemically active layer 26 may be made of one of the noble metals, such as platinum, palladium, gold or a combination of any of the aforesaid with iridium. In a set of preferred embodiments, other noble metals are used in layer 26. A number of strategies are possible for making plated core or wire 20.
  • a tube of platinum is prepared and molten stainless steel, tantalum or nitinol is poured inside of it, to form a filled tube.
  • the filled tube is then drawn through progressively smaller apertures, until its diameter reaches the desired thickness.
  • Another issue with drawn filled tubes is that it is difficult to reduce the thickness of the layer of platinum to less than 20 microns. This increases the expense because it forces the use of a greater than otherwise necessary amount of platinum.
  • Another method starts with a robust metal wire that is then electroplated with platinum. In this method the robust metal wire is typically negatively charged to form a cathode. A plating solution bath is positively charged to form an anode.
  • the first step is to plate the stainless steel with an intermediate layer that bonds well to both stainless steel and platinum.
  • this layer is gold, although it has been found to be advantageous to plate a first intermediate layer of nickel, plate gold over this layer of nickel and finally plate the gold with platinum.
  • the plating solution may be either acid or alkaline .
  • a core of nitinol was used.
  • gold is plated over the nitinol.
  • hydrofluoric acid is included in the gold bath to strip away any oxidation that may have formed on the nitinol.
  • a core of robust metal is clad in platinum foil.
  • cladding in the neighborhood of 5 to 15 microns is possible.
  • a metallic vapor is created and coats the core 24.
  • a wire of structurally robust metal 24, such as tantalum is passivated, meaning that a thin layer of oxide is created on the exterior of the wire.
  • platinum is vaporized in a plasma environment, and deposition of layer 26 on the tantalum wire results.
  • a robust coating 26 of platinum or another electrochemically active metal
  • the layer 26 of platinum is electrically isolated from the structurally sound metal 24 by a layer of oxide, which is nonconducting. Accordingly, if there is a pinhole in the platinum 26, there will nevertheless be no electrical contact between the body fluid and the underlying core 24 of structurally sound metal. If body fluid were to contact core 24, unpredictable electrical activity could result, potentially corrupting the measurement.
  • an electrochemically active metal may be deposited on a continuous wire of structurally sound metal, designed to host many sensing sites.
  • sputtering in which free metallic charged particles are created, may be used to perform the coating or cladding step. Both plasma vapor deposition and sputtering are well known in the art.
  • a strike, or extremely thin ( ⁇ 5 microns) coating of gold is first electroplated onto the stainless steel core. Then, platinum is electroplated in a bath having a current density on the order of 40 amperes/ft 2 or less. It is important to electroplate with a comparatively low current density, causing a slow buildup of platinum, in order to prevent uneven growth of the platinum layer.
  • the membrane system 22 must perform a number of functions. First, it must provide an enzyme that reacts with glucose and oxygen (or glucose only in some preferred embodiments) to form an electrolyte.
  • Other enzymes may be used for this process and fall within the scope of this invention.
  • system 22 must include a membrane placed over the reactive layer 30 to permit a greater permeation of oxygen than glucose, so that the glucose concentration measurement is not limited by the oxygen concentration in the immediately surrounding tissue. This function is performed by a permselective hard block/soft block copolymer layer 32. This layer is of the type described in U.S.
  • Layer 32 is preferably less than 10 microns thick, to permit rapid permeation by glucose and oxygen.
  • membrane system 22 must prevent interferents, such as acetaminophen, from corrupting the measurement by causing current flow unrelated to the presence of glucose. This function is performed by an inner interferent reducing layer 34 of a compound such as sulfonated polyether sulfone, 3-amino-phenol, or polypyrrole, which quickly permits the permeation of the hydrogen peroxide, which causes the current flow indicative of the concentration of glucose.
  • the interferent reducing layer 34 of 3-amino-phenol is solution-coated or electro polymerized onto the surface of platinum plating 26.
  • Layer 34 may be from a few nanometers to 2 microns thick, to permit rapid permeation by H 2 0 2 ions, thereby reacting very quickly to glucose concentration.
  • the reactive layer 30 of glucose oxidase is dip-coated or electrodeposited.
  • Glutaraldehyde is deposited on the glucose oxidase to immobilize the glucose oxidase.
  • the sensor is dip coated in the soft block/hard block copolymer 32.
  • the surface of the sensing region 22 is slightly depressed relative the remainder of the surface of sensing element 12.
  • the glucose oxidase 30 is applied before layer 34, which is electrodeposited through layer 30.
  • a voltage is placed between contacts 72 at the beginning of the measurement process. When electrical current flows between contacts 72, this indicates that body fluid has completely wet membrane system 22 and serves as a signal to place a voltage on conductor 24.
  • a layer of absorbent metal is included over membrane system 22.
  • sensing element 12 may be either inserted into the body of a number of days and may provide a multiplicity of glucose measurement or may be used as a single use sensing element.
  • sensing element 12 When used as for a single use, sensing element 12 may be part of a multiple sensing element assembly. The measurement of glucose concentration may occur when sensing element 12 is briefly indwelling, or may occur after it has been withdrawn, with retained body fluid being tested.
  • a single use element 12 is typically optimized to provide a fast readout, whereas a sensing element that dwells within the body for days is typically optimized for accuracy over time and for to satisfy the greater safety challenge posed by an indwelling device.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

L'invention concerne un détecteur (12) destiné à être introduit au moins partiellement dans le corps d'un mammifère. Ce détecteur (12) est formé d'une partie noyau comprenant un métal (24) structurellement robuste et d'une partie plaquée comprenant un métal (26) électrochimiquement actif associé à une partie au moins du noyau (24). Ce détecteur (12) peut être utilisé dans une méthode permettant de mesurer en continu un analyte dans le corps d'un mammifère. Cette méthode consiste à introduire au moins une partie du capteur (12) dans le corps d'un mammifère et à mesurer un éventuel courant électrique produit par une partie au moins du détecteur (12).
EP04776794A 2004-06-16 2004-06-16 Detecteur d'analyte en metal composite Ceased EP1765148A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11153393A EP2335566A1 (fr) 2004-06-16 2004-06-16 Capteur d'analytes métalliques composés

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/019648 WO2005074810A1 (fr) 2004-06-16 2004-06-16 Detecteur d'analyte en metal composite

Publications (2)

Publication Number Publication Date
EP1765148A1 true EP1765148A1 (fr) 2007-03-28
EP1765148A4 EP1765148A4 (fr) 2008-09-24

Family

ID=34839166

Family Applications (2)

Application Number Title Priority Date Filing Date
EP11153393A Ceased EP2335566A1 (fr) 2004-06-16 2004-06-16 Capteur d'analytes métalliques composés
EP04776794A Ceased EP1765148A4 (fr) 2004-06-16 2004-06-16 Detecteur d'analyte en metal composite

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP11153393A Ceased EP2335566A1 (fr) 2004-06-16 2004-06-16 Capteur d'analytes métalliques composés

Country Status (5)

Country Link
EP (2) EP2335566A1 (fr)
JP (1) JP4681606B2 (fr)
CN (1) CN1988846A (fr)
CA (1) CA2570895A1 (fr)
WO (1) WO2005074810A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100198033A1 (en) * 2009-02-05 2010-08-05 Peter Krulevitch Flexible indwelling biosensor, flexible indwelling biosensor insertion device, and related methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436329A (en) * 1964-12-11 1969-04-01 Beckman Instruments Inc Microelectrode and method of making same
US3957613A (en) * 1974-11-01 1976-05-18 General Electric Company Miniature probe having multifunctional electrodes for sensing ions and gases
JPH0560722A (ja) * 1991-08-30 1993-03-12 Japan Storage Battery Co Ltd グルコースセンサ
US5221456A (en) * 1991-10-22 1993-06-22 Rosemount Inc. Insulated core electrode for ph sensor
WO1993022360A1 (fr) 1992-04-24 1993-11-11 The Polymer Technology Group, Inc. Copolymeres et membrane non-poreuse, semi-permeable de ceux-ci, et son utilisation pour impregner des molecules presentant une plage de masses moleculaires predeterminee
US5589563A (en) 1992-04-24 1996-12-31 The Polymer Technology Group Surface-modifying endgroups for biomedical polymers
US5522977A (en) * 1994-10-07 1996-06-04 Biomedix, Inc. Glucose sensor
DE69910003T2 (de) * 1998-05-13 2004-04-22 Cygnus, Inc., Redwood City Überwachung physiologischer analyte
US6793632B2 (en) * 2001-06-12 2004-09-21 Lifescan, Inc. Percutaneous biological fluid constituent sampling and measurement devices and methods
US6501976B1 (en) * 2001-06-12 2002-12-31 Lifescan, Inc. Percutaneous biological fluid sampling and analyte measurement devices and methods
US7162289B2 (en) * 2002-09-27 2007-01-09 Medtronic Minimed, Inc. Method and apparatus for enhancing the integrity of an implantable sensor device
US7120483B2 (en) * 2003-01-13 2006-10-10 Isense Corporation Methods for analyte sensing and measurement
US6965791B1 (en) * 2003-03-26 2005-11-15 Sorenson Medical, Inc. Implantable biosensor system, apparatus and method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO2005074810A1 *

Also Published As

Publication number Publication date
JP4681606B2 (ja) 2011-05-11
EP1765148A4 (fr) 2008-09-24
CA2570895A1 (fr) 2005-08-18
WO2005074810A1 (fr) 2005-08-18
JP2008502902A (ja) 2008-01-31
CN1988846A (zh) 2007-06-27
EP2335566A1 (fr) 2011-06-22

Similar Documents

Publication Publication Date Title
US7146202B2 (en) Compound material analyte sensor
CA2789814C (fr) Appareils capteurs d'analyte ayant des configurations d'electrodes ameliorees, et leurs procedes de fabrication et d'utilisation
US9439585B2 (en) Semiconductor based analyte sensors and methods
CA3056105C (fr) Structures de dispositifs a piliers metalliques et procedes de fabrication et d'utilisation dans des applications electrochimiques et/ou electrocatalytiques
JP2009515571A (ja) 白金電極表面被膜及びその作製方法
CA2502277A1 (fr) Detecteurs de substances a analyser et leurs procedes de fabrication
US20130296664A1 (en) Biosensor and Method for Providing a Biosensor
US20040127966A1 (en) Stimulation electrode and methods of making and using same
TW201010670A (en) Electrode system for measuring an analyte concentration under in-vivo conditions
US20240167977A1 (en) Electrodes having at least one sensing structure and methods for making and using the same
KR102275188B1 (ko) 비효소적으로 혈당을 측정하는 미세침 전극 센서 및 이의 제조하는 방법
CN114767105B (zh) 植入式电化学生物传感器、测试方法及植入式医疗器械
CN106645336B (zh) 一种多孔金属修饰表面的微针电极及其制备方法
EP2335566A1 (fr) Capteur d'analytes métalliques composés
US20200029869A1 (en) Nonenzymatic determination of glucose at near neutral ph values based on the use of nafion and platinum black coated microneedle electrode array
CA2381714A1 (fr) Capteurs et procedes analytiques d'utilisation
CN114324529B (zh) 一种连续电化学检测的微电极、生物传感器及制备方法
US20220008717A1 (en) Multilayer ring electrode having a plurality of openings
Tran Towards Non-Invasive Continuous Glucose Monitoring: A Study on Minimally Invasive Enzymatic Microneedle Biosensors
WO2010148441A1 (fr) Dispositif de contrôle du lactate

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061213

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102191

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20080825

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 27/333 20060101ALI20080820BHEP

Ipc: C12Q 1/00 20060101ALI20080820BHEP

Ipc: A61B 5/00 20060101AFI20050819BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ISENSE CORPORATION

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WARD, KENNETH W

Inventor name: SASS, RICHARD S

17Q First examination report despatched

Effective date: 20090206

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20131022

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102191

Country of ref document: HK